C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2002
12/10/2002	US6492504 Nucleotide sequence of mammastatin and methods of use
12/10/2002	US6492499 Human pancreatitis-associated protein
12/10/2002	US6492498 A fusion protein molecule comprising a toxic domain, a targeting domain, and at least one heterologous coupling moiety, wherein cysteine residues forming disulfide bonds
12/10/2002	US6492497 Specific binding members for TGFbeta1
12/10/2002	US6492496 Antibodies to the receptor protein designated 2F1
12/10/2002	US6492495 PTP-S31: a novel protein tyrosine phosphatase
12/10/2002	US6492493 Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
12/10/2002	US6492343 Porcine adenovirus type 3 genome
12/10/2002	US6492331 NL8 tie ligands homologues
12/10/2002	US6492325 Use of α1β1 integrin receptor inhibitors and TGF-β1 inhibitors in the treatment of kidney disease
12/10/2002	US6492185 Immunoassay for detection of very low density lipoprotein and antibodies useful therefor
12/10/2002	US6492177 Kit for use in treatment of polycystic ovarian disease
12/10/2002	US6492167 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects
12/10/2002	US6492160 Methods for producing members of specific binding pairs
12/10/2002	US6492157 Methods are provided for the treatment of conditions associated with cells proliferation, cells differentiation and cell survival. in particular, the dual-specificity phosphatase dsp-9, and polypeptide variants thereof that
12/10/2002	US6492140 Polynucleotides encoding cytokine designated LERK-5
12/10/2002	US6492138 Polynucleotides encoding a novel SHC-binding protein
12/10/2002	US6492129 Fragments comprising the n-terminal region of connective tissue growth factor (ctgf); screening for inhibitors or stimulators of ctgf
12/10/2002	US6492126 Compositions and methods for the treatment and diagnosis of cardiovascular disease
12/10/2002	US6492125 Method to assess library X library interactions
12/10/2002	US6492123 Polypeptides comprising a first domain of an immunoglobulin heavy chain variable region, and a second domain of an immunoglobulin light chain variable region, linked but incapable of associating with each other; assay for antigen
12/10/2002	US6491956 Food containing active strains for inhibiting infection and treating gastritis, gastric and duodenal ulcers
12/10/2002	US6491926 35 kD tumor associated protein antigen: uses and methods of detection
12/10/2002	US6491924 Sequence of at least 5 consecutive amino acids in the polypeptide of seq id no: 1
12/10/2002	US6491920 Polypeptides and DNA encoding same
12/10/2002	US6491918 Antibody compositions for preparing enriched dendritic cell preparations
12/10/2002	US6491917 Antibody composition for debulking blood and bone marrow samples from CML patients
12/10/2002	US6491916 Nontoxic antibodies comprising epitopes, complements and point-mutated human immunoglobulin fc fragments, having reduced lymphocyte mitogens, administered for suppression of graft versus host diseases, before, during or after surgery
12/10/2002	US6491915 Anti-CCR2 antibodies and methods of use therefor
12/10/2002	US6491914 Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions including the anti-idiotypic monoclonal antibodies
12/10/2002	US6491871 System for determining receptor-ligand binding affinity
12/10/2002	US6491391 System, apparatus, and method for reducing birefringence
12/10/2002	CA2212150C Monoclonal antibodies for human osteogenic cell surface antigens
12/10/2002	CA2114015C Recombinant antibodies for human therapy
12/10/2002	CA2080182C Nuclear inhibitor i-92 and its use for the production of a medicament
12/10/2002	CA2077764C Antibody to pacap and use thereof
12/10/2002	CA2047290C Recombinant marek's disease virus
12/10/2002	CA1341407C Minactivin
12/08/2002	CA2817619A1 Methods of administering anti-tnf.alpha. antibodies
12/08/2002	CA2385745A1 Methods of administering anti-tnf.alpha. antibodies
12/05/2002	WO2002097395A2 P-cadherin as a target for anti-cancer therapy
12/05/2002	WO2002097122A1 Secretion of proteins by encapsulated cells
12/05/2002	WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	WO2002097110A2 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF
12/05/2002	WO2002097094A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
12/05/2002	WO2002097079A2 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene
12/05/2002	WO2002097075A2 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
12/05/2002	WO2002097060A2 Carbohydrate-associated proteins
12/05/2002	WO2002097048A2 ANTI-p40 IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
12/05/2002	WO2002097046A2 B7 related protein-2 molecules and uses thereof
12/05/2002	WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	WO2002097043A2 Wnv core protein/capsid interacting protein and uses of the same
12/05/2002	WO2002097042A2 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
12/05/2002	WO2002097041A2 Fusion proteins of biologically active peptides and antibodies
12/05/2002	WO2002097035A2 Secreted proteins
12/05/2002	WO2002097033A2 Antibodies that immunospecifically bind to trail receptors
12/05/2002	WO2002097032A2 Proteins associated with cell growth, differentiation, and death
12/05/2002	WO2002097030A2 Peptides derived from neural thread proteins and their medical use
12/05/2002	WO2002096951A1 Molecules for disease detection and treatment
12/05/2002	WO2002096949A1 Antigen targeting
12/05/2002	WO2002096948A2 Engineered tetravalent antibodies and methods of use
12/05/2002	WO2002096945A2 Macrophage receptor agonist or antagonist
12/05/2002	WO2002096937A2 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
12/05/2002	WO2002096932A1 Transporters and ion channels
12/05/2002	WO2002096461A1 Use of anti-tnf antibodies as drugs in treating septic disorders of anemic patients
12/05/2002	WO2002096460A1 Endopeptidase/anti-psma antibody fusion proteins for treatment of cancer
12/05/2002	WO2002096458A1 Anti-ngf antibodies for the treatment of various disorders
12/05/2002	WO2002096457A2 Stable liquid formulations of antibodies
12/05/2002	WO2002096456A1 Use of il-18 inhibitors for treating or preventing cns injuries
12/05/2002	WO2002096455A2 Use of polyclonal immunoglobulins
12/05/2002	WO2002096452A1 Siglec-12 polypeptides, polynucleotides, and methods of use thereof
12/05/2002	WO2002096437A1 Neutron capture therapy
12/05/2002	WO2002082089A3 Anti-idiotypic antibody and its use in diagnosis and therapy of hepatitis c virus related diseases
12/05/2002	WO2002070557A3 Nuclear hormone receptor ligand binding domain
12/05/2002	WO2002068470A3 Interferon-alpha induced gene
12/05/2002	WO2002059155A3 Modulation of calcium channel activity
12/05/2002	WO2002053749A3 Regulation of human serine-threonine protein kinase
12/05/2002	WO2002051863A3 Polypeptides having a triggering nk activity and biological applications
12/05/2002	WO2002047728A3 Treatment of posterior capsule opacification
12/05/2002	WO2002038732A3 Human testis specific serine/threonine kinase
12/05/2002	WO2002030985A3 Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection
12/05/2002	WO2002028902A3 Nectin polypeptides, polynucleotides, methods of making and use thereof
12/05/2002	WO2002028351A9 Recombinant mucin binding proteins from steptococcus pneumoniae
12/05/2002	WO2002013862A3 Method and composition for altering a b cell mediated pathology
12/05/2002	WO2002012468A3 2,5-dkg permeases
12/05/2002	WO2002000715A3 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof
12/05/2002	WO2001097608A3 Cyk-4 polypeptides, dna molecules encoding them and their use in screening methods
12/05/2002	WO2001092491A3 Mammalian protein phosphatases identified by in-silico analysis
12/05/2002	WO2001088085A3 Novel bee venom polypeptides and methods of use thereof
12/05/2002	WO2001085947A3 Compounds and methods for the diagnosis and treatment of babesia microti infection
12/05/2002	WO2001079448A3 Trp8, a transient receptor potential channel expressed in taste receptor cells
12/05/2002	WO2001060397A9 Uses of agonists and antagonists to modulate activity of tnf-related molecules
12/05/2002	WO2001032926A3 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
12/05/2002	WO2001021796A9 Gl50 molecules and uses therefor
12/05/2002	US20020183508 Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
12/05/2002	US20020183505 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183504 Isolated gene of given sequence, from the family of aspartate-specific cysteine proteases (ASCPs); involved in apoptosis
12/05/2002	US20020183503 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of immunological, infectious, inflammatory and cancer disorders
12/05/2002	US20020183500 Nucleotide sequence coding polypeptide for use in the treatment, diagnosis, classification and imaging of lung cancer
12/05/2002	US20020183497 High affinity humanized anti-TAG-72 monoclonalantibodies

1 ... 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 ... 1494